15 results about "Cornea repair" patented technology

The invention discloses a PDRNamp and a method for preparing the PDRNamp. The invention discloses EGT eye wash as well as a preparation method and application thereof, and belongs to the technical field of eye care products. The eye wash is prepared from the following active components in percentage by mass: 0.001 to 0.01 percent of PDRN, 0.03 to 0.1 percent of EGT (Ergothioneine), sodium hyaluronate, sodium chloride, taurine and the like, wherein the mass percent of the PDRN is 0.001 to 0.01 percent, and the mass percent of the EGT is 0.03 to 0.1 percent. Through the synergistic effect of PDRN and EGT, the product has excellent cornea repairing capacity and a powerful anti-oxidation function at the same time, and the moisturizing and soothing effects are enhanced by compounding sodium hyaluronate and taurine. The obtained eye washing liquid is an isotonic solution with neutral pH, is mild and non-irritating, does not contain preservatives, can effectively achieve multiple nursing effects of eye cleaning, moisturizing, repairing, anti-inflammatory and anti-oxidation, and is suitable for relieving xerophthalmia, assisting cornea repair and daily anti-oxidation nursing of eyes.

The invention relates to the technical field of medical preparations, in particular to moisturizing and repairing type artificial tear as well as a preparation method and application thereof. Comprising the following steps: preparing effective components including high-molecular-weight polydeoxyribonucleotide and hyaluronic acid or a salt thereof into a homogeneous-phase stable composite solution, sterilizing, filtering, and aseptically packaging, the artificial tear formed by selecting high-molecular-weight polydeoxyribonucleotide and high-molecular-weight sodium hyaluronate as effective components has a relatively good repairing effect on tissues, can form long-term moisturizing and lubrication on ocular surfaces, is suitable for treating xerophthalmia, repairing cornea, relieving inflammatory response and the like, and has a good application prospect. Important market values and clinical application prospects are realized.

The utility model relates to a matrix lens corneal donor based on hydrogel bonding, and the corneal donor comprises a plurality of layers of corneal matrix lenses which are stacked along the thickness direction of the corneal matrix lenses; and the bonding layer is bonded between two adjacent cornea stroma lenses, and the bonding layer comprises composite material hydrogel which forms a grid porous structure after being cured. The stacked multiple layers of cornea stroma lenses are bonded to the preset thickness through the combined adhesive, so that the cornea donor has high structural strength, the problem of sliding or twisting deformation in the surgical suture process is effectively avoided, a grid porous structure is formed after composite hydrogel is cured, and the cornea donor has a good application prospect. The air permeability and the structural strength of the matrix lens cornea donor based on hydrogel bonding are guaranteed, and the reliability of cornea repair is improved.

The application discloses an oxygen-enriched recombinant human I / V type collagen corneal repair gel and a preparation method thereof. Methyl methacrylic acid is added into recombinant human I / V type collagen to prepare a methyl methacrylate anhydride recombinant human collagen RHC-I / V-MA solution, the solution is dissolved in an EDC solution for reaction for 2-4 hours to obtain a RHC-I / V-MA-EDC sponge-like solid sample, then the sample is dissolved in a photoinitiator to obtain a mixed solution, an oxygen-containing gas is continuously introduced into the mixed solution by using a micro-nano bubble generator, the flow rate of the oxygen-containing gas is 0.1-2 L / min, and the oxygen-containing gas is introduced for 1-15 minutes to obtain the oxygen-enriched recombinant human I / V type collagen corneal repair gel. The light transmittance of the oxygen-enriched recombinant human I / V type collagen corneal repair gel is extremely high in a spectral range of 400-700 nm, the oxygen-enriched recombinant human I / V type collagen corneal repair gel has good optical stability, is suitable for repairing a corneal transparent layer and provides a material selection with excellent optical performance for corneal repair.

The application provides application of calcium folinate in preparation of corneal repair promoting drugs and belongs to the technical field of ophthalmic drugs. The application uses calcium folinate as an active ingredient of a drug for treating corneal injury, has a good treatment effect on corneal epithelial injury and corneal nerve injury, and the calcium folinate is low in price and easy to store. The application provides a calcium folinate eye drop solution, which comprises calcium folinate and physiological saline; the mass percentage content of the calcium folinate in the calcium folinate eye drop solution is 0.1-1%. Compared with the drugs commonly used in the clinic for promoting repair after corneal injury, the calcium folinate eye drop solution provided by the application is low in price, can reduce the medical expenditure of patients to a certain extent, and reduces the medical burden of patients. Meanwhile, the composition of the calcium folinate is single, the calcium folinate is easy to store and not prone to deterioration, and the application of the calcium folinate to a certain extent avoids the risk that the existing corneal repair promoting eye drop solution is continuously used after being contaminated and deteriorated, which may cause or aggravate the infection risk.

The invention discloses oxygen-enriched recombinant human I / V type collagen cornea repair gel and a preparation method thereof.The preparation method comprises the steps that methacrylic acid is added into recombinant human I type collagen and recombinant human V type collagen, a methacrylic anhydride recombinant human collagen RHC-I / V-MA solution is prepared and then dissolved in an EDC solution, a reaction is conducted for 2-4 h, and an RHC-I / V-MA-EDC spongy solid sample is obtained; dissolving in a photoinitiator to obtain a mixed solution; a micro-nano bubble generator is adopted to continuously introduce oxygen-containing gas into the mixed solution, the introduction flow of the gas is 0.1-2 L / min, the introduction time is 1-15 min, and the oxygen-enriched recombinant human I / V type collagen cornea repair gel is obtained. The material prepared by the method has high light transmittance in a spectral range of 400-700nm, has good optical stability, is suitable for repairing a cornea transparent layer, and provides a material selection with excellent optical performance for cornea repair.

The invention provides a structure bionic collagen corneal graft and a preparation method thereof. The preparation method of the collagen corneal graft with the bionic structure comprises the following steps: S1, dissolving collagen to prepare a collagen solution; s2, adding a cross-linking agent into the collagen solution to carry out a cross-linking reaction; and S3, carrying out bubble removal, molding, freeze thawing, freeze drying, washing and drying on the cross-linking reaction product to prepare the structure bionic collagen corneal graft. The water content of the collagen cornea graft with the bionic structure is similar to that of a natural cornea, the light transmittance performance is good, the light transmittance and a light transmittance curve in a visible light range are not greatly different from those of tissues, the ion permeability performance and the biomechanical performance are good, and the requirements of nutrient substance transportation and eyeball supporting and protecting effects can be met; particularly, the cornea graft has excellent suture resistance, can bear suture and tearing of operation lines, and has a good cornea repair effect.

The invention discloses a water-soluble cellulose derivative-silk fibroin artificial tear with the characteristics of long-acting retention and no irritation and a preparation method thereof. The artificial tear comprises a water-soluble cellulose derivative, silk fibroin, an osmotic pressure regulator, a pH regulator and water. After the water-soluble cellulose derivative is dissolved, a transparent viscous colloid can be formed, a protective film can be formed on the ocular surface, a tear film is stabilized, tear evaporation is delayed, friction is reduced, and dryness and foreign body sensation are rapidly relieved. The polar group of the silk fibroin and the silk fibroin form a stable network through a hydrogen bond, eyelid shearing and tear erosion are resisted, the bioavailability of the silk fibroin is improved, and the silk fibroin has the effects of resisting inflammation and promoting corneal epithelium repair. The osmotic pressure regulator and the pH regulator are cooperated, so that the osmotic pressure and the pH value of the artificial tear approach to those of human tears, the ocular surface is prevented from being stimulated, and the medication comfort and compliance are improved. The artificial tear can quickly relieve the dry eye symptom, realizes long-acting cornea repair, and provides a new strategy for development of a high-efficiency long-acting eye drug delivery system.

The invention relates to the field of medicines, in particular to fluoroalkanes, and a composition, a preparation method and application thereof. The invention has the following advantages: the invention provides fluoroalkane, and a composition, a preparation method and application thereof; the compound shown in the formula (I) or the pharmaceutically acceptable salt, the stereoisomer, the isotope variant, the solvate or the composition of the compound has the effects of stabilizing a tear film, dissolving meibolipid, dissolving earwax, inhibiting evaporation of water on the ocular surface, increasing the thickness of a tear film lipid layer, improving the spreadability of cornea, wetting the surface of the eye, preserving an isolated organ, improving the stability of the cornea and improving the quality of the eye. The pharmaceutical composition has the effects of improving the stability of a tear film, reducing the evaporation rate of tears, prolonging the rupture time of the tear film, treating meibomian fat abnormity, treating meibomian gland dysfunction, treating keratoconjunctivitis sicca, treating eye or ear related diseases such as xerophthalmia related diseases and / or delivering active pharmaceutical ingredients.

The invention discloses a nano ophthalmic gel preparation for treating corneal epithelium injury. The main component of the nano ophthalmic gel preparation is PIP nano gel; the preparation method of the PIP nanogel comprises the following steps: preparing cystamine dihydrochloride modified carboxymethyl cellulose from cystamine dihydrochloride modified carboxymethyl cellulose, taking collagen as an auxiliary material, loading a drug component PIP under the action of electrostatic self-assembly, and synthesizing the PIP nanogel. The hydrated particle size of the synthesized PIP nanogel is 50 to 500 nm. The ball-like PIP nanogel with good dispersion is proposed and successfully prepared for the first time, the blank that no suitable PIP delivery system exists in the prior art is filled, and a new technical path is provided for in-vivo application of PIP; the prepared nano ophthalmic gel preparation can prolong the PIP eye residence time to 12 hours or more, so that the cornea repair speed is increased by 50% or more compared with that of a free PIP group, and wound closure is accelerated.

The invention relates to a drug-loaded hydrogel eye pad as well as a preparation method and application thereof, and belongs to the technical field of eye care and pharmaceutical preparations. The drug-loaded hydrogel eye pad is composed of a hydrogel matrix and active components uniformly dispersed in the hydrogel matrix, the active components are salvianolic acid B and geniposide, and the mass ratio of the salvianolic acid B to the geniposide is 4: 1-1.5: 1. According to the drug-loaded hydrogel eye patch provided by the invention, gelatin and chitosan are taken as matrixes, a hydrogel network is formed through genipin crosslinking, and salvianolic acid B and geniposide are loaded as active ingredients. Salvianolic acid B can inhibit release of inflammatory factors, improve microcirculation and promote corneal repair; the geniposide has remarkable anti-inflammatory, anti-oxidation and neuroprotective effects, and the geniposide and the geniposide synergistically play a role in treating xerophthalmia. The eye patch has good biocompatibility, adhesion and drug release performance, can effectively relieve xerophthalmia symptoms, and is simple in preparation process and suitable for large-scale production.

The invention provides gel for eyes and a preparation method thereof, and belongs to the field of eye medicaments, and the gel for eyes is composed of 16 natural components which synergistically exert multiple effects. Chrysanthemum and menthol can relieve asthenopia and dryness, and the cactus extract forms a moisturizing film to lock moisture and improve the stability of a tear film; and the honeysuckle and the scutellaria baicalensis inhibit pathogenic bacteria of eyes. Lutein can filter blue light and resist oxidation, and semen cassiae and radix ophiopogonis can prevent retina injury; the Chinese herbaceous peony extract and white swallow promote corneal repair and enhance ocular surface resistance. The gel base material adopts a thermo-sensitive graft copolymer, and phase transformation is triggered by body temperature after the gel base material is dropped into eyes, so that gel is formed, the residence time is prolonged, the biological barrier of the eyes is broken through, and the utilization rate of effective components is increased. And the auxiliary agents EDTA-2Na and xanthan gum enhance the stability and adhesion of the gel, and the gel is mild and non-irritant. According to the gel, natural components are combined with an intelligent delivery technology, discomfort such as eye dryness, itching and fatigue can be relieved, safety and high efficiency are achieved, and comprehensive protection is provided for eye health.

The invention provides a CXCL7 gene targeting composition and application of the CXCL7 gene targeting composition in preparation of a medicine for treating fungal keratitis, and relates to the field of biological medicine. The composition disclosed by the invention is formed by transfecting a carrier containing a CXCL7 targeted interference sequence, and the CXCL7 targeted interference sequence is shown as SEQ ID No.1. The vector is an adeno-associated virus vector, and the CXCL7 targeting interference sequence is inserted into the downstream of a U6 promoter of the adeno-associated virus vector. According to the invention, CXCL7 is used as a new target of fungal keratitis, expression of CXCL7 is inhibited by means of gene intervention, the problems of excessive immune response and difficult control of inflammatory response are solved, and accurate local treatment is realized by an AAV vector system; in addition, excessive activation of immune response can be effectively relieved, excessive aggregation of immune cells is reduced, secretion of inflammatory factors is reduced, accordingly, inflammatory response of the cornea is relieved, and cornea repair is helped.